Acquisitions - Schedule Of Business Combination, Intangible Asset, Acquired (Details) - Akoya Biosciences, Inc. - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
Jul. 08, 2025 |
Mar. 31, 2026 |
Jun. 30, 2026 |
|
| Business Combination [Line Items] | |||
| Definite-lived intangible assets: | $ 102,500 | ||
| Weighted Average Useful Life (in years) | 9 years 7 months 6 days | ||
| Total intangible assets | $ 121,800 | ||
| In process research and development | |||
| Business Combination [Line Items] | |||
| Indefinite-lived intangible assets: | $ 19,300 | $ 19,300 | |
| Developed technology | |||
| Business Combination [Line Items] | |||
| Definite-lived intangible assets: | $ 99,600 | ||
| Weighted Average Useful Life (in years) | 9 years 7 months 6 days | ||
| Customer relationships | |||
| Business Combination [Line Items] | |||
| Definite-lived intangible assets: | $ 2,900 | ||
| Weighted Average Useful Life (in years) | 9 years 2 months 12 days |
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase in finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in indefinite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|